RoverMed Alternatives & Competitors
12 companies similar to RoverMed
Companies similar to RoverMed
OncoSolutions
CyCa OncoSolutions developed a nanomachine for drug delivery and cell labeling in Cork, Ir...
Capstan Therapeutics
Advancing cell engineering to develop therapeutics for a broad range of diseases
Ashvattha Therapeutics, Inc.
Harnessing the power of hydroxyl dendrimers to create a new class of disease cell-targeted...
Track all RoverMed competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
Immusoft
Cell therapy company dedicated to improving the lives of patients with rare diseases
NovaXS Biotech Corp.
Delivering future therapeutics within your grasp.
Microchips Inc
Enhancing patient care with a unique implant delivering precise drug doses over extended p...
ESPERANCE PHARMACEUTICALS, INC.
Pioneering a new era of anticancer treatment with drugs that precisely target and eliminat...
ReNeuron Group Plc
Developing the next generation of Engineered Exosomes.
Alivio Therapeutics
Pioneering precision immunomodulation to tackle chronic and acute inflammatory disorders a...
About RoverMed
RoverMed is a biotechnology startup founded in 2016 that has developed a revolutionary drug delivery system. This system is designed to carry medication exclusively into the nuclei of targeted cells, regardless of their location within the body. The company operates within the Biotechnology, Health Care, and Life Scien...
Drug Delivery, Medication, Nuclei Targeting, Cell Targeting, Medical Technology
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches RoverMed and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at RoverMed on 11 Sep 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.